Ledger.Open graph →
SEC Form D · filed December 28, 2021

Psy Therapeutics, Inc

Offering
$20.4M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jeff S. Troderman · Boston, MAExecJerry F. Rosenbaum · Boston, MADirectorWilliam F. Wagner · Boston, MAExecDaniel S. Weiss Pick · Boston, MADirectorAlan S. Cross · Boston, MADirectorDavid S. Barlow · Boston, MAExec · DirectorChristopher G. Carter · DALLAS, TXDirectorPhillip Mertz · Vancouver, British Columbia, CanadaExecGiada De Laurentiis · Los Angeles, CAExecCastle Ridge Ltd · Grand Cayman, Cayman IslandsDirectorB.P. Martiuk · Grand Cayman, Cayman IslandsExec · DirectorAdrian De Valois-Franklin · Toronto, Ontario, CanadaDirectorKarl O'Reilly · Grand Cayman, Cayman IslandsExec · DirectorMarc V. Teillon · SAN FRANCISCO, CADirectorStephen A. Foster · SAN FRANCISCO, CADirectorKyle A. Kuczynski · Reno, NVDirectorWilliam P. Vernon · Reno, NVExecJason D. Molt · Reno, NVExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗